Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ward Knutson who wrote (10812)	3/4/2004 2:02:18 PM
From: rkrw	Read Replies (3) \| Respond to of 52153

OT Ward, I've long seen mogn as a cult stock esp back then. Sorry if this offends you, but that's my opinion. Sounds like you were on top of the anti-emetic, that's great. I still remember mogn (and you I believe) pointing to a single (maybe a couple) cancer patient who was doing very well. I've considered this type of push a red flag. I remember well Rick's argument that the mogn drug was toxic as hell. Was he right? mogn made a very shrewd inlicensing and deserves much credit for this. It's nice to see a stock with long time and loyal s/h getting rewarded for their perseverance. lgnd is a similar one with LT and loyal s/h that's doing very well via a smart inlicensing. P.S. Sign of a cult stock, say anything disparaging and you'll hear about it and fast. Glad that you and Richard are sharing beers. Kudo's. I should have been right there with you, perhaps at the next table over :-)